Literature DB >> 6159375

Basis of antifibrinolytic therapy.

C R Prentice.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 6159375      PMCID： PMC1347103     

Source DB:  PubMed          Journal:  J Clin Pathol Suppl (R Coll Pathol)        ISSN： 0144-0330


× No keyword cloud information.
  33 in total

Review 1.  Indications for antifibrinolytic therapy.

Authors:  C R Prentice
Journal:  Thromb Diath Haemorrh       Date:  1975-12-15

2.  In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor.

Authors:  A H Dubber; G P McNicol; D Uttley; A S Douglas
Journal:  Br J Haematol       Date:  1968-01       Impact factor: 6.998

3.  Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.

Authors:  H Landmann
Journal:  Thromb Diath Haemorrh       Date:  1973-05-10

4.  Differences in the binding to fibrin of urokinase and tissue plasminogen activator.

Authors:  S Thorsen; P Glas-Greenwalt; T Astrup
Journal:  Thromb Diath Haemorrh       Date:  1972-08-31

5.  [Standardization of protease inhibitor from cattle organs].

Authors:  F Markwardt; M Richter
Journal:  Pharmazie       Date:  1969-10       Impact factor: 1.267

6.  The defibrination syndrome: clinical features and laboratory diagnosis.

Authors:  C Merskey; A J Johnson; G J Kleiner; H Wohl
Journal:  Br J Haematol       Date:  1967-07       Impact factor: 6.998

7.  The reactive site of the basic trypsin in hibitor of pancreas. Role of lysine 15.

Authors:  J Chauvet; R Acher
Journal:  J Biol Chem       Date:  1967-09-25       Impact factor: 5.157

8.  Biochemistry and toxicology of amikapron; the antifibrinolytically active isomer of AMCHA. (A comparative study with epsilon-aminocaproic acid).

Authors:  B Melander; G Gliniecki; B Granstrand; G Hanshoff
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1965

9.  Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease.

Authors:  C D Forbes; R D Barr; G Reid; C Thomson; C R Prentice; G P McNicol; A S Douglas
Journal:  Br Med J       Date:  1972-05-06

10.  Plasminogen-activator-producing tumour.

Authors:  J F Davidson; G P McNicol; G L Frank; T J Anderson; A S Douglas
Journal:  Br Med J       Date:  1969-01-11
View more
  14 in total

Review 1.  Haemostatic drugs for traumatic brain injury.

Authors:  Pablo Perel; Ian Roberts; Haleema Shakur; Bandit Thinkhamrop; Nakornchai Phuenpathom; Surakrant Yutthakasemsunt
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

2.  Three-dimensionally printed biological machines powered by skeletal muscle.

Authors:  Caroline Cvetkovic; Ritu Raman; Vincent Chan; Brian J Williams; Madeline Tolish; Piyush Bajaj; Mahmut Selman Sakar; H Harry Asada; M Taher A Saif; Rashid Bashir
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

3.  Pepsin fibrinolysis of artificial clots made from fibrinogen concentrate and bovine thrombin: the effect of pH and epsilon aminocaproic acid.

Authors:  G A Valenzuela; W D Spotnitz; D D Stone
Journal:  Surg Endosc       Date:  1989       Impact factor: 4.584

4.  Late postoperative massive bleeding in septorhinoplasty: A prospective study.

Authors:  Safvet Ors; Mehmet Ozkose
Journal:  Plast Surg (Oakv)       Date:  2016-05-27       Impact factor: 0.947

5.  Management of subarachnoid haemorrhage.

Authors:  M Vermeulen; G J Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

6.  Benefits of Limited Use of a Tourniquet Combined With Intravenous Tranexamic Acid During Total Knee Arthroplasty.

Authors:  Alexander D Rosenstein; Yehuda A Michelov; Stephanie Thompson; Alan D Kaye
Journal:  Ochsner J       Date:  2016

7.  Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms.

Authors:  Suraj Kachgal; Andrew J Putnam
Journal:  Angiogenesis       Date:  2010-11-21       Impact factor: 9.596

8.  The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial.

Authors:  Haleema Shakur; Diana Elbourne; Metin Gülmezoglu; Zarko Alfirevic; Carine Ronsmans; Elizabeth Allen; Ian Roberts
Journal:  Trials       Date:  2010-04-16       Impact factor: 2.279

Review 9.  Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.

Authors:  Lise J Estcourt; Michael Desborough; Susan J Brunskill; Carolyn Doree; Sally Hopewell; Michael F Murphy; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2016-03-15

10.  Intracerebral haemorrhage after thrombolytic therapy for acute myocardial infarction.

Authors:  R S More; R Vincent
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.